Rheumatology patient recall software: labs, infusions, follow-ups (2026)

Rheumatology patient recall software watches every patient's therapy calendar and brings them in when an interval opens: the methotrexate patient due for a CBC and liver panel, the infliximab patient eight weeks past the last infusion, the rheumatoid arthritis patient not yet at target who needs a three-month disease activity check, the osteoporosis patient due for denosumab. It reads those intervals from the EHR, reaches each patient by phone, text, and email in the practice's voice, books the lab, chair, or visit, and reports found, reached, booked, and seen. In rheumatology the recall calendar is written by the drug, not the visit type.

This guide covers the data on monitoring and adherence gaps, what recall software actually does, how rheumatology recall differs from other specialties, what it should connect to, and a six-step rollout for a practice running Epic, athenahealth, eClinicalWorks, or NextGen.

Key Takeaways

• In a 2025 survey of DMARD patients, 8.1% had missed or delayed monitoring bloods by more than a month on at least two of their last ten occasions, and more than half of monitoring happened in primary care rather than at the rheumatology practice.
• Patients in a real-world electronic study took oral methotrexate in only 77% of monitored weeks, so a lab recall is often the first signal that therapy itself has lapsed.
• Rheumatology patients whose scheduling was delayed were far more likely to no-show, so recall has to book the visit in the same conversation, not just announce it is due.
• The rheumatology workforce is projected to remain short of need through 2030, so a recall that keeps established patients on interval protects capacity that cannot be replaced.
• Recall software should report found, reached, booked, seen by recall type: labs, infusions, disease activity follow-ups, and screening.

The Data Behind the Decision

A 2025 survey of 630 patients on conventional and biologic DMARDs found that 8.1% had missed or delayed their monitoring blood tests by more than a month on at least two of their last ten occasions, that the recommended methotrexate interval was three months, and that 53.2% of monitoring took place in primary care rather than secondary care (Rheumatology Advances in Practice, 2025). When the lab is drawn elsewhere, the practice learns it was skipped only when the patient shows up for a visit, or does not.

The lab lapse usually travels with a dosing lapse. When Forward, the National Databank for Rheumatic Diseases, monitored oral methotrexate electronically for 24 weeks, patients took the dose in 77% of monitored weeks, and one in four showed major deviations or discontinued (ACR Annual Meeting abstract, 2017). A recall for a missed CBC often surfaces that the patient stopped the drug weeks earlier.

Recall also has to book, not just notify. Across 2,167 rheumatology referrals in one regional health system, patients who no-showed had waited 33.4 days between the referral and calling to schedule, against 9 days for patients who arrived (ACR Convergence abstract, 2021). A recall message that says "please call to schedule" recreates that delay. And 82% of patients try to book care outside a practice's regular office hours, so the reply to a recall text usually arrives when the phones are off.

Capacity makes the case. The adult rheumatology workforce grew 23% between 2009 and 2019, from 4,557 to 5,667 physicians, yet the projection for 2030 is roughly 7,000 rheumatologists against a need of 8,100 (Arthritis and Rheumatology, 2024). Every established patient kept on interval is one who does not become an urgent referral into a months-long wait list.

What does rheumatology recall software actually do?

It continuously scans the practice's records against interval rules the practice sets. For each patient it reads the active medication list, the last resulted labs, the last infusion date, the last disease activity score, and the last visit, then opens a recall when any interval passes without an order or appointment on the books. It reaches the patient by phone, text, and email in one two-way thread, from the practice's number and in the practice's voice, and it books the lab draw, the chair, or the visit while the patient is in the conversation. It syncs the booking to the EHR and the infusion schedule. And it reports found, reached, booked, seen.

That is the difference from tools that only send reminders. A reminder needs an appointment to exist first. Recall exists to create the appointment that should exist and does not. The general checklist is in what patient recall software should do; the rheumatology version below is about which intervals to load.

How is recall different in rheumatology?

The recall calendar is drug-driven. Methotrexate and leflunomide need a CBC, metabolic panel, and liver panel roughly every 8 to 12 weeks once stable. Biologics and JAK inhibitors carry their own monitoring rules. Infusions run on fixed cadences: infliximab every eight weeks in maintenance, tocilizumab and abatacept monthly by IV, rituximab in six-month courses, zoledronic acid annually, denosumab every six months with a real rebound risk if it slips. Hydroxychloroquine patients need retinal screening on a schedule an ophthalmologist owns but the rheumatologist is responsible for. Treat-to-target care adds a three-month disease activity follow-up for any patient not at low disease activity. A single patient can be on four of those calendars at once.

The second difference is where the data lives. Labs are often drawn at a primary care office or an outside lab, infusions may run in a separate infusion center system, and the rheumatologist's EHR sees the results only if the interfaces are in place. Recall software has to read from all of it or the found list is wrong from the first day.

The third difference is the patient. Rheumatology panels are older, Medicare heavy, and full of questions: whether to hold methotrexate before the draw, whether the infusion is still covered, whether a flare should move the visit up. Recall in rheumatology is a conversation with a booking at the end, not a notification.

What should recall software connect to, and what does it cost?

It needs the EHR and practice management system (Epic, athenahealth, eClinicalWorks, NextGen), the lab results interface, the infusion scheduling system, and the phone system. Pricing runs per provider, per patient reached, or per booked visit. Compare vendors on cost per patient seen, by recall type. A single blended number hides which recall type is broken.

How to run patient recall in a rheumatology practice: 6 steps

1. Write the interval table. One row per drug or program: monitoring labs, infusion cadence, screening, disease activity follow-up. Physicians sign it once. The software reads it.
2. Connect the data sources. EHR medication list, resulted labs including outside results, infusion schedule, last visit. Test with 20 known patients before turning outreach on.
3. Prioritize by consequence. Denosumab past interval and biologic patients with no monitoring labs go first. Stable annual follow-ups go last.
4. Book in the conversation. Every recall message offers open lab, chair, or visit slots and confirms the booking in the same thread, including at night and on weekends.
5. Route the questions. Hold-the-dose questions, flare reports, and coverage concerns go to the nurse or the authorization coordinator with the thread attached. Booking stays automated.
6. Review found, reached, booked, seen monthly by recall type. Fix the lowest-converting type first. It is usually the one where the slot did not exist.

What Should Still Go to a Human?

The interval rules themselves belong to the physicians, and any change to a patient's monitoring schedule is a clinical decision. Abnormal results that surface during recall go to the nurse, not to an automated message. Whether to hold a drug before a procedure, whether a flare needs a same-day visit, and any dispute about infusion coverage or a denied authorization go to a person. The software's job is to recognize those moments in the thread and hand them off with full context.

Where Clinekt Fits

Clinekt is the patient activation platform for specialty practices: four AI agents that share one memory of every patient and cover the whole journey, from first click to the care between visits. Recall is the Recall Agent. It continuously scans the practice's records for overdue follow-ups, lapsed care plans, monitoring intervals that opened, ordered-but-never-scheduled visits, and dormant charts, reaches those patients by phone, text, and email in one two-way thread in the practice's voice, books them into open slots, and reports found, reached, booked, seen. Between visits, the Care Management Agent runs monthly check-ins by call or text, collects validated patient-reported measures, flags concerning answers to staff, and logs consent, care plans, and minutes so the biller can bill from the audit trail. The Inbound Agent answers the patient who replies at 10 p.m. Clinekt OS is the one memory behind all of it, so the patient recalled for a lab in March is recognized when they text about an infusion in October.

Our published result is orthopedic: Baldwin Bone and Joint generated 263 qualified surgical leads and 159 booked appointments, a 60% booking rate, in a single quarter. Recall depends on the same mechanism: a reason and an open slot in one conversation. More than one million patient interactions have been completed across the platform. Deployment is live the same day, with no IT project, no new staff workflow, and a sync to the EHR. Clinekt is HIPAA compliant and SOC 2 Type II. See the full platform, measure the care your practice is losing with the leakage calculator, and book a demo.

Frequently Asked Questions

What recall intervals should a rheumatology practice load first?
The ones with the clearest clinical consequence: methotrexate and leflunomide monitoring labs every 8 to 12 weeks once stable, infusion cadence by drug, denosumab every six months, hydroxychloroquine retinal screening, and a three-month treat-to-target follow-up for patients not yet at low disease activity.

Is recall software the same as appointment reminders?
No. A reminder confirms an appointment that already exists. Recall finds the patient who has no appointment but should, because a lab, infusion, or follow-up interval has opened, then reaches them and books the visit. Reminders reduce no-shows; recall closes gaps in care.

How does recall software know when a methotrexate lab is due?
It reads the medication list and the last resulted CBC, metabolic panel, and liver panel from the EHR, applies the interval the practice set for that drug, and opens a recall when the interval passes with no order scheduled. Outside lab results have to flow in or the recall list will be wrong.

Can recall software book infusion chair time, not just office visits?
It should. Infusion recall only works if the patient lands in a chair on the right date, so the software needs to see chair availability, the drug on order, and the authorization status, and write the booking back to the infusion schedule as well as the EHR.

What should the recall report show every month?
Found (patients whose interval opened), reached (a real two-way contact), booked, and seen, by recall type. A practice that sees only messages sent cannot tell whether infusion recall or lab recall is failing.

Put your DMARD and infusion panel into the leakage calculator to see how much monitored care is slipping past its interval, then book a demo and we will build the interval table with you.